Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by 13N-Ammonia Perfusion PET in Patients With Hypertrophic Cardiomyopathy
- PMID: 27771003
- DOI: 10.1016/j.amjcard.2016.08.085
Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by 13N-Ammonia Perfusion PET in Patients With Hypertrophic Cardiomyopathy
Abstract
Vasodilator-induced transient left ventricular (LV) cavity dilation by positron emission tomography (PET) is common in patients with hypertrophic cardiomyopathy (HC). Because most patients with PET-LV cavity dilation lack obstructive epicardial coronary artery disease, we hypothesized that vasodilator-induced subendocardial hypoperfusion resulting from microvascular dysfunction underlies this result. To test this hypothesis, we quantified myocardial blood flow (MBF) (subepicardial, subendocardial, and global MBF) and left ventricular ejection fraction (LVEF) in 104 patients with HC without significant coronary artery disease, using 13NH3-PET. Patients with HC were divided into 2 groups, based on the presence/absence of LV cavity dilation (LVvolumestress/LVvolumerest >1.13). Transient PET-LV cavity dilation was evident in 52% of patients with HC. LV mass, stress left ventricular outflow tract gradient, mitral E/E', late gadolinium enhancement, and prevalence of ischemic ST-T changes after vasodilator were significantly higher in patients with HC with LV cavity dilation. Baseline LVEF was similar in the 2 groups, but LV cavity dilation+ patients had lower stress-LVEF (43 ± 11 vs 53 ± 10; p <0.001), lower stress-MBF in the subendocardial region (1.6 ± 0.7 vs 2.3 ± 1.0 ml/min/g; p <0.001), and greater regional perfusion abnormalities (summed difference score: 7.0 ± 6.1 vs 3.9 ± 4.3; p = 0.004). The transmural perfusion gradient, an indicator of subendocardial perfusion, was similar at rest in the 2 groups. Notably, LV cavity dilation+ patients had lower stress-transmural perfusion gradients (0.85 ± 0.22, LV cavity dilation+ vs 1.09 ± 0.39, LV cavity dilation-; p <0.001), indicating vasodilator-induced subendocardial hypoperfusion. The stress-transmural perfusion gradient, global myocardial flow reserve, and stress-LVEF were associated with LV cavity dilation. In conclusion, diffuse subendocardial hypoperfusion and myocardial ischemia resulting from microvascular dysfunction contribute to development of transient LV cavity dilation in HC.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a 13NH3 gated PET study.Eur J Nucl Med Mol Imaging. 2017 May;44(5):866-875. doi: 10.1007/s00259-016-3603-2. Epub 2017 Jan 3. Eur J Nucl Med Mol Imaging. 2017. PMID: 28050630
-
Higher incidence of vasodilator-induced left ventricular cavity dilation by PET when compared to treadmill exercise-ECHO in hypertrophic cardiomyopathy.J Nucl Cardiol. 2020 Dec;27(6):2031-2043. doi: 10.1007/s12350-018-01521-x. Epub 2018 Nov 19. J Nucl Cardiol. 2020. PMID: 30456498
-
Validation of pixel-wise parametric mapping of myocardial blood flow with ¹³NH₃ PET in patients with hypertrophic cardiomyopathy.Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1581-8. doi: 10.1007/s00259-015-3101-y. Epub 2015 Jun 27. Eur J Nucl Med Mol Imaging. 2015. PMID: 26121929
-
Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography.Eur Heart J Cardiovasc Imaging. 2013 Feb;14(2):95-101. doi: 10.1093/ehjci/jes242. Epub 2012 Nov 14. Eur Heart J Cardiovasc Imaging. 2013. PMID: 23152441 Review.
-
Myocardial perfusion dependent and independent mechanisms of regional myocardial dysfunction in hypertrophy.Basic Res Cardiol. 1993;88 Suppl 1:81-95. doi: 10.1007/978-3-642-72497-8_6. Basic Res Cardiol. 1993. PMID: 8357337 Review.
Cited by
-
Single-nucleus RNA/ATAC-seq in early-stage HCM models predicts SWI/SNF-activation in mutant-myocytes, and allele-specific differences in fibroblasts.bioRxiv [Preprint]. 2024 Apr 24:2024.04.24.589078. doi: 10.1101/2024.04.24.589078. bioRxiv. 2024. PMID: 38903075 Free PMC article. Preprint.
-
Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model.CJC Open. 2021 Feb 2;3(6):801-813. doi: 10.1016/j.cjco.2021.01.016. eCollection 2021 Jun. CJC Open. 2021. PMID: 34169259 Free PMC article.
-
Relationship of Subendocardial Perfusion to Myocardial Injury, Cardiac Structure, and Clinical Outcomes Among Patients With Hypertension.Circulation. 2024 Oct;150(14):1075-1086. doi: 10.1161/CIRCULATIONAHA.123.067083. Epub 2024 Aug 21. Circulation. 2024. PMID: 39166326
-
Myocardial Perfusion Imaging with Cardiovascular Magnetic Resonance in Nonischemic Cardiomyopathies: An In-Depth Review of Techniques and Clinical Applications.Medicina (Kaunas). 2025 May 10;61(5):875. doi: 10.3390/medicina61050875. Medicina (Kaunas). 2025. PMID: 40428833 Free PMC article. Review.
-
Adding clinical value with coronary flow assessment in hypertrophic obstructive cardiomyopathy.Int J Cardiol Heart Vasc. 2020 Apr 4;27:100512. doi: 10.1016/j.ijcha.2020.100512. eCollection 2020 Apr. Int J Cardiol Heart Vasc. 2020. PMID: 32310245 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources